Use Latest Tech To Develop Green Pharma City: CM Revanth Reddy To Officials

HYDERABAD: Directing officials to expedite the development of Green Pharma City at Mucharla, Chief Minister A Revanth Reddy said that the latest global technology available should be used for its development.

On Monday, the chief minister held a review meeting with officials. He directed them to take all measures necessary to ensure that Green Pharma City remains environmentally sustainable and free from pollution. He stressed that industrial development should not cause any inconvenience to the people in surrounding areas.

Revanth told them to construct roads and take steps to provide drinking water, electricity, drainage and other essential infrastructure. He also instructed officials to assess future needs and plan infrastructure accordingly. He mentioned that several prominent pharmaceutical companies are already expressing interest in investing in Green Pharma City, and the government will soon begin consultations with them.

The chief minister said the Green Pharma City should become a one-stop hub for drug manufacturing companies, as well as biotech and life sciences firms. He highlighted that priority will be given to the production of antibiotics, fermentation products, synthetic drugs, chemicals, vitamins, vaccines, drug formulations, nutraceuticals, herbal medicinal products, specialty chemicals, cosmetics, and related products. Additionally, research and development will be a major focus.

He announced that a special university will be established within the city for research, training and skill development, with courses designed to enhance employment opportunities in the healthcare and pharma sectors.

IT and Industries Minister D Sridhar Babu, Chief Secretary Santhi Kumari, Principal Secretary (Industries) Department Jayesh Ranjan and other officials attended the meeting.

Related Posts

CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

Milan: CPHI Milan 2026, one of the pharmaceutical industry’s largest global events, has launched four specialist zones designed to connect pharmaceutical companies with the technologies, services and expertise shaping the…

Lilly takes 6 companies to court for selling retatrutide knockoffs

Washington: Eli Lilly’s experimental weight-loss drug retatrutide has yet to be approved by the FDA. But the buzz surrounding the effectiveness of the compound—commonly known as triple-G—has already triggered a…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

Lilly takes 6 companies to court for selling retatrutide knockoffs

Lilly takes 6 companies to court for selling retatrutide knockoffs

FDA Busts Abortion Medicine Racket in Nagpur, Solapur; IndiaMART Directors among 8 Booked

FDA Busts Abortion Medicine Racket in Nagpur, Solapur; IndiaMART Directors among 8 Booked

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch